PL2530093T3 - Związek indocyjaninowy, jego metoda syntezy, metoda jego oczyszczania, kompozycja diagnostyczna wykorzystująca związek indocyjaninowy oraz urządzenie do pomiaru biokinetyki in vivo i urządzenie do wizualizacji krążenia wykorzystujące kompozycję diagnostyczną - Google Patents
Związek indocyjaninowy, jego metoda syntezy, metoda jego oczyszczania, kompozycja diagnostyczna wykorzystująca związek indocyjaninowy oraz urządzenie do pomiaru biokinetyki in vivo i urządzenie do wizualizacji krążenia wykorzystujące kompozycję diagnostycznąInfo
- Publication number
- PL2530093T3 PL2530093T3 PL11736813T PL11736813T PL2530093T3 PL 2530093 T3 PL2530093 T3 PL 2530093T3 PL 11736813 T PL11736813 T PL 11736813T PL 11736813 T PL11736813 T PL 11736813T PL 2530093 T3 PL2530093 T3 PL 2530093T3
- Authority
- PL
- Poland
- Prior art keywords
- diagnostic composition
- indocyanine compound
- measuring
- synthesis method
- vivo kinetics
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 2
- 238000001727 in vivo Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000000746 purification Methods 0.000 title 1
- 238000001308 synthesis method Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0071—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by measuring fluorescence emission
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/0205—Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/026—Measuring blood flow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/20—Measuring for diagnostic purposes; Identification of persons for measuring urological functions restricted to the evaluation of the urinary system
- A61B5/201—Assessing renal or kidney functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
- A61B5/415—Evaluating particular organs or parts of the immune or lymphatic systems the glands, e.g. tonsils, adenoids or thymus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
- A61B5/418—Evaluating particular organs or parts of the immune or lymphatic systems lymph vessels, ducts or nodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7271—Specific aspects of physiological measurement analysis
- A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient ; user input means
- A61B5/742—Details of notification to user or communication with user or patient ; user input means using visual displays
- A61B5/7425—Displaying combinations of multiple images regardless of image source, e.g. displaying a reference anatomical image with a live image
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0032—Methine dyes, e.g. cyanine dyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0032—Methine dyes, e.g. cyanine dyes
- A61K49/0034—Indocyanine green, i.e. ICG, cardiogreen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0054—Macromolecular compounds, i.e. oligomers, polymers, dendrimers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
- A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
- A61K49/0089—Particulate, powder, adsorbate, bead, sphere
- A61K49/0091—Microparticle, microcapsule, microbubble, microsphere, microbead, i.e. having a size or diameter higher or equal to 1 micrometer
- A61K49/0093—Nanoparticle, nanocapsule, nanobubble, nanosphere, nanobead, i.e. having a size or diameter smaller than 1 micrometer, e.g. polymeric nanoparticle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/007—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests for contrast media
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
- C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B23/00—Methine or polymethine dyes, e.g. cyanine dyes
- C09B23/0066—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain being part of a carbocyclic ring,(e.g. benzene, naphtalene, cyclohexene, cyclobutenene-quadratic acid)
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B23/00—Methine or polymethine dyes, e.g. cyanine dyes
- C09B23/02—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain containing an odd number of >CH- or >C[alkyl]- groups
- C09B23/08—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain containing an odd number of >CH- or >C[alkyl]- groups more than three >CH- groups, e.g. polycarbocyanines
- C09B23/086—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain containing an odd number of >CH- or >C[alkyl]- groups more than three >CH- groups, e.g. polycarbocyanines more than five >CH- groups
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B68/00—Organic pigments surface-modified by grafting, e.g. by establishing covalent or complex bonds, in order to improve the pigment properties, e.g. dispersibility or rheology
- C09B68/40—Organic pigments surface-modified by grafting, e.g. by establishing covalent or complex bonds, in order to improve the pigment properties, e.g. dispersibility or rheology characterised by the chemical nature of the attached groups
- C09B68/48—Non-aromatic cyclic groups
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B68/00—Organic pigments surface-modified by grafting, e.g. by establishing covalent or complex bonds, in order to improve the pigment properties, e.g. dispersibility or rheology
- C09B68/40—Organic pigments surface-modified by grafting, e.g. by establishing covalent or complex bonds, in order to improve the pigment properties, e.g. dispersibility or rheology characterised by the chemical nature of the attached groups
- C09B68/48—Non-aromatic cyclic groups
- C09B68/485—Substituted non-aromatic cyclic groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2576/00—Medical imaging apparatus involving image processing or analysis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/026—Measuring blood flow
- A61B5/0275—Measuring blood flow using tracers, e.g. dye dilution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B68/00—Organic pigments surface-modified by grafting, e.g. by establishing covalent or complex bonds, in order to improve the pigment properties, e.g. dispersibility or rheology
- C09B68/40—Organic pigments surface-modified by grafting, e.g. by establishing covalent or complex bonds, in order to improve the pigment properties, e.g. dispersibility or rheology characterised by the chemical nature of the attached groups
- C09B68/41—Polymers attached to the pigment surface
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Organic Chemistry (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Medical Informatics (AREA)
- Surgery (AREA)
- Epidemiology (AREA)
- Polymers & Plastics (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Physiology (AREA)
- Vascular Medicine (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Nanotechnology (AREA)
- Endocrinology (AREA)
- Radiology & Medical Imaging (AREA)
- Signal Processing (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Artificial Intelligence (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Psychiatry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Anesthesiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010017255 | 2010-01-28 | ||
JP2010132923 | 2010-06-10 | ||
PCT/JP2011/000489 WO2011093098A1 (ja) | 2010-01-28 | 2011-01-28 | 新規インドシアニン化合物、その合成法及びその精製法、そのインドシアニン化合物を用いた診断用組成物、その診断用組成物を使用する生体内動態測定装置、並びに循環可視化装置 |
EP11736813.4A EP2530093B1 (en) | 2010-01-28 | 2011-01-28 | Indocyanine compound, synthesis method thereof, purification method thereof, diagnostic composition using indocyanine compound, and device for measuring in vivo kinetics and device for visualizing circulation using diagnostic composition |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2530093T3 true PL2530093T3 (pl) | 2019-06-28 |
Family
ID=44319092
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL11736813T PL2530093T3 (pl) | 2010-01-28 | 2011-01-28 | Związek indocyjaninowy, jego metoda syntezy, metoda jego oczyszczania, kompozycja diagnostyczna wykorzystująca związek indocyjaninowy oraz urządzenie do pomiaru biokinetyki in vivo i urządzenie do wizualizacji krążenia wykorzystujące kompozycję diagnostyczną |
Country Status (10)
Country | Link |
---|---|
US (5) | US9056131B2 (pl) |
EP (1) | EP2530093B1 (pl) |
JP (1) | JP5721234B2 (pl) |
CN (2) | CN106977628B (pl) |
DK (1) | DK2530093T3 (pl) |
ES (1) | ES2708697T3 (pl) |
HU (1) | HUE041616T2 (pl) |
PL (1) | PL2530093T3 (pl) |
PT (1) | PT2530093T (pl) |
WO (1) | WO2011093098A1 (pl) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106977628B (zh) | 2010-01-28 | 2021-04-13 | 国立大学法人三重大学 | 吲哚菁化合物、其合成及精制法、诊断用组合物、生物体内动态测定装置及循环可视化装置 |
JP6029050B2 (ja) * | 2012-06-22 | 2016-11-24 | 国立大学法人三重大学 | 血管透過性亢進評価剤、血管透過性亢進評価方法、および血管透過性亢進評価装置 |
US9750827B2 (en) | 2013-02-22 | 2017-09-05 | Canon Kabushiki Kaisha | Near-infrared dye-conjugated hyaluronic acid derivative and contrast agent for optical imaging including them |
US10323104B2 (en) | 2014-08-02 | 2019-06-18 | Lg Chem, Ltd. | Dye complex, photoconversion film and electronic element including same |
US10245329B2 (en) * | 2014-09-08 | 2019-04-02 | Canon Kabushiki Kaisha | Composition having dye and conjugate of polyethyleneglycol and additive and contrast agent for photoacoustic imaging having the same |
GB2568550B (en) * | 2017-11-21 | 2021-06-30 | Univ Cape Town | Method of synthesising 6-deoxy-6-amino-ß-d-glucopyranoside-containing polymers |
WO2019217583A1 (en) * | 2018-05-09 | 2019-11-14 | Board Of Trustees Of Michigan State University | Near-infrared harvesting transparent luminescent solar concentrators with engineered stokes shift |
US20220096662A1 (en) * | 2019-02-01 | 2022-03-31 | Nanyang Technological University | Molecular renal probes for detecting acute kidney injury |
CN111134622B (zh) * | 2019-05-24 | 2021-03-02 | 四川大学华西医院 | 一种无创检测体内吲哚菁绿含量的装置 |
WO2021105888A1 (en) | 2019-11-27 | 2021-06-03 | Astellas Pharma, Inc. | Crystal of indocyanine compound |
CN112891557A (zh) * | 2021-02-03 | 2021-06-04 | 柯阳 | 一种ICG-β-环糊精载药系统及其制备方法和应用 |
WO2022202863A1 (ja) * | 2021-03-24 | 2022-09-29 | アステラス製薬株式会社 | がん造影用組成物 |
MX2024001242A (es) | 2021-07-28 | 2024-02-13 | Astellas Pharma Inc | Una composicion farmaceutica para la obtencion de imagenes. |
CN118284438A (zh) | 2021-11-26 | 2024-07-02 | 安斯泰来制药株式会社 | 含有吲哚菁化合物的固体药物组合物 |
US20240125703A1 (en) | 2022-09-16 | 2024-04-18 | Stryker Corporation | Systems and methods for quantifying user observed visualization of fluorescence imaging agents |
WO2024084287A1 (en) | 2022-10-21 | 2024-04-25 | Astellas Pharma Inc. | Composition for near infrared lymphatic imaging and uses and dosages therefor |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1276833B1 (it) | 1995-10-09 | 1997-11-03 | Sorin Biomedica Cardio Spa | Coloranti fluorescenti della famiglia della solfo benz e indocianina |
US5877310A (en) | 1997-04-25 | 1999-03-02 | Carnegie Mellon University | Glycoconjugated fluorescent labeling reagents |
WO1999051284A2 (en) | 1998-04-03 | 1999-10-14 | Mallinckrodt Inc. | Non-covalent bioconjugates useful for diagnosis and therapy |
JP2000095758A (ja) * | 1998-09-18 | 2000-04-04 | Schering Ag | 近赤外蛍光造影剤および蛍光造影方法 |
JP4041613B2 (ja) * | 1999-03-12 | 2008-01-30 | 富士フイルム株式会社 | 画像形成材料 |
US6939532B2 (en) * | 2000-01-18 | 2005-09-06 | Mallinckrodt, Inc. | Versatile hydrophilic dyes |
US6656451B1 (en) | 2000-10-16 | 2003-12-02 | Mallinckrodt, Inc. | Indole compounds as novel dyes for organ function monitoring |
AU2003218116A1 (en) | 2002-03-12 | 2003-09-29 | Beth Israel Deaconess Medical Center | Medical imaging systems |
EP1760467A1 (en) * | 2005-09-02 | 2007-03-07 | Schering AG | Optically fluorescent nanoparticles |
WO2007106142A2 (en) | 2006-02-24 | 2007-09-20 | Mallinckrodt Inc. | Process for using optical agents |
CA2692923A1 (en) | 2006-07-03 | 2008-06-26 | Beth Israel Deaconess Medical Center, Inc. | Intraoperative imaging methods |
WO2008016139A1 (fr) | 2006-08-04 | 2008-02-07 | Osaka University | Dérivé fluorescent d'oléamide et ses utilisations |
US8343463B2 (en) * | 2009-07-31 | 2013-01-01 | Numira Biosciences Inc. | Optical imaging agent |
JP5817073B2 (ja) | 2010-01-28 | 2015-11-18 | 国立大学法人三重大学 | 新規インドシアニン化合物を用いた診断用組成物及び分析方法 |
CN106977628B (zh) * | 2010-01-28 | 2021-04-13 | 国立大学法人三重大学 | 吲哚菁化合物、其合成及精制法、诊断用组合物、生物体内动态测定装置及循环可视化装置 |
-
2011
- 2011-01-28 CN CN201710146571.XA patent/CN106977628B/zh active Active
- 2011-01-28 DK DK11736813.4T patent/DK2530093T3/en active
- 2011-01-28 HU HUE11736813A patent/HUE041616T2/hu unknown
- 2011-01-28 ES ES11736813T patent/ES2708697T3/es active Active
- 2011-01-28 WO PCT/JP2011/000489 patent/WO2011093098A1/ja active Application Filing
- 2011-01-28 US US13/575,810 patent/US9056131B2/en active Active
- 2011-01-28 JP JP2011551776A patent/JP5721234B2/ja active Active
- 2011-01-28 EP EP11736813.4A patent/EP2530093B1/en active Active
- 2011-01-28 PT PT11736813T patent/PT2530093T/pt unknown
- 2011-01-28 PL PL11736813T patent/PL2530093T3/pl unknown
- 2011-01-28 CN CN201180006735XA patent/CN102770460A/zh active Pending
-
2015
- 2015-02-06 US US14/616,117 patent/US9844606B2/en active Active
-
2017
- 2017-02-21 US US15/438,047 patent/US10086090B2/en active Active
-
2018
- 2018-08-13 US US16/101,544 patent/US10350310B2/en active Active
-
2019
- 2019-05-10 US US16/408,495 patent/US11344632B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
HUE041616T2 (hu) | 2019-05-28 |
ES2708697T3 (es) | 2019-04-10 |
US9056131B2 (en) | 2015-06-16 |
US20190262477A1 (en) | 2019-08-29 |
EP2530093B1 (en) | 2018-11-21 |
US10086090B2 (en) | 2018-10-02 |
CN102770460A (zh) | 2012-11-07 |
US9844606B2 (en) | 2017-12-19 |
JPWO2011093098A1 (ja) | 2013-05-30 |
DK2530093T3 (en) | 2019-01-28 |
PT2530093T (pt) | 2018-12-28 |
US11344632B2 (en) | 2022-05-31 |
US20150152267A1 (en) | 2015-06-04 |
CN106977628A (zh) | 2017-07-25 |
EP2530093A4 (en) | 2016-07-06 |
JP5721234B2 (ja) | 2015-05-20 |
CN106977628B (zh) | 2021-04-13 |
EP2530093A1 (en) | 2012-12-05 |
WO2011093098A1 (ja) | 2011-08-04 |
US20180353626A1 (en) | 2018-12-13 |
US20120302881A1 (en) | 2012-11-29 |
US20170157273A1 (en) | 2017-06-08 |
US10350310B2 (en) | 2019-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL2530093T3 (pl) | Związek indocyjaninowy, jego metoda syntezy, metoda jego oczyszczania, kompozycja diagnostyczna wykorzystująca związek indocyjaninowy oraz urządzenie do pomiaru biokinetyki in vivo i urządzenie do wizualizacji krążenia wykorzystujące kompozycję diagnostyczną | |
SI2364302T1 (sl) | Tirazinski analogi in njihova uporaba kot terapevtska sredstva in diagnostične sonde | |
HUE047414T2 (hu) | Berendezés Raman spektroszkópiával történõ nem invazív in vivo méréshez | |
HK1199807A1 (en) | Device for non-invasively measuring glucose | |
IL213410A0 (en) | Methods and compositions for diagnostic use in cancer patients | |
EP2531110A4 (en) | APPARATUS FOR DENTAL TOMODENSITOMETRY | |
EP2503942A4 (en) | COMPUTER-ASSISTED TOMOGRAPHY APPARATUS FOR ODONTOLOGY | |
IL222605A0 (en) | Apparatus and kit for encapsulating at least one compound for therapeutic and/or diagnostic use in erythrocytes | |
EP2340851A4 (en) | DIAGNOSTIC METHOD AND THERAPEUTIC METHOD FOR CANCER | |
FI20090444A0 (sv) | Odontologisk datortomografiapparatur | |
EP2187198A4 (en) | BLOOD EXAMINATION APPARATUS | |
HRP20171443T1 (hr) | Postupak za pripremanje jodiranog kontrastnog sredstva | |
EP2257316A4 (en) | CONTRAST AGENTS, METHODS FOR PREPARING CONTRAST AGENTS, AND IMAGING METHODS | |
EP2321320A4 (en) | NEW COMPOUNDS AND THEIR USES IN DIAGNOSIS | |
BR112012009859A2 (pt) | composição de diagnóstico, método de diagnóstico, e, método de detecção de formação de imagem in vivo | |
GB201016038D0 (en) | In vivo imaging method | |
GB201012209D0 (en) | In vivo imaging agent | |
HK1211465A1 (en) | Solid oral composition containing dyes for use in endoscopic diagnosis | |
GB201212105D0 (en) | Diagnostic device for monitoring blood microcirculation parameters "in vivo" | |
PT2364302T (pt) | Análogos de triazina e a sua utilização como agentes terapêuticos e sondas de diagnóstico | |
PL2364302T3 (pl) | Analogi triazyny i ich zastosowanie jako środki terapeutyczne oraz sondy diagnostyczne | |
IL222464A (en) | Device does not penetrate glucose measurement | |
HU1000657D0 (en) | Method for diagnosing artery stiffness and endotheli-function using pulse-wave analysis | |
GB201011045D0 (en) | Diagnostic agent for parkinsons disease | |
GB0801973D0 (en) | In vivo imaging method |